Here we report the identification of a previously uncharacterized human
protein as the human
monolysocardiolipin acyltransferase-1 (MLCL AT-1). Pig liver mitochondria were treated with
n-butyl alcohol followed by Q-
Sepharose chromatography, preparative gel electrophoresis,
cytidine diphosphate-1,2-diacyl-sn-glycerol-Sepharose chromatography, and finally
monolysocardiolipin-
adriamycin-
agarose affinity chromatography. Elution with either
monolysocardiolipin or
linoleoyl coenzyme A revealed a major band at 74 kDa with high specific activity (2,300 pmol/min/mg) for the acylation of
monolysocardiolipin to
cardiolipin using [1-(14)C]
linoleoyl coenzyme A as substrate. Matrix-assisted
laser desorption ionization time-of-flight-mass spectrometry analysis followed by search of the Mascot
protein data base revealed
peptide matches consistent with a 59-kDa
protein identified as unknown human
protein (GenBank(TM)
protein accession number AAX93141;
nucleotide accession number AC011742.3). The purified human recombinant MLCL AT-1
protein utilized
linoleoyl coenzyme A >
oleoyl coenzyme A >
palmitoyl coenzyme A for the specific acylation of
monolysocardiolipin to
cardiolipin. Expression of MLCL AT-1 in HeLa cells increased mitochondrial
monolysocardiolipin acyltransferase activity and [1-(14)C]
linoleic acid incorporated into
cardiolipin, whereas RNA interference knockdown of MLCL AT-1 in HeLa cells resulted in reduction in
enzyme activity and [1-(14)C]
linoleic acid incorporated into
cardiolipin. In contrast, expression of MLCL AT-1 in HeLa cells did not alter [1-(14)C]oleic or [1-(14)C]
palmitate incorporation into
cardiolipin indicating in vivo specificity for the remodeling of
cardiolipin with
linoleate. Finally, expression of MLCL AT-1 in
Barth syndrome lymphoblasts, which exhibit
cardiolipin levels 20% that of normal lymphoblasts, increased mitochondrial
monolysocardiolipin acyltransferase activity, [1-(14)C]
linoleic acid incorporation into
cardiolipin,
cardiolipin mass, and
succinate dehydrogenase (mitochondrial complex II) activity compared with mock-transfected
Barth syndrome lymphoblasts. The results identify MLCL AT-1 as a human mitochondrial
monolysocardiolipin acyltransferase involved in the remodeling of
cardiolipin.